Showing 101 - 120 results of 14,818 for search '"Mao"', query time: 0.16s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113

    Anti-obesity effect of irreversible MAO-B inhibitors in patients with Parkinson’s disease by Siyu Liang, Yuxin Sun, Shi Chen, Hui Pan

    Published 2024-11-01
    “…Abstract We read with great interest the report on the new anti-obesity potential in mice models of reversible monoamine oxidase B inhibitors by Moonsun et al., as opposed to the lack of such effects observed with irreversible MAO-B inhibitors (iMAO-Bi). Our research aimed to explore the potential anti-obesity effects of iMAO-Bi in patients with Parkinson’s disease (PD). …”
    Get full text
    Article
  14. 114

    Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors by Mehmet Abdullah Alagöz, Jong Min Oh, Yaren Nur Zenni, Zeynep Özdemir, Mohamed A. Abdelgawad, Ibrahim A. Naguib, Mohammed M. Ghoneim, Nicola Gambacorta, Orazio Nicolotti, Hoon Kim, Bijo Mathew

    Published 2022-06-01
    “…Sixteen compounds (<b>TR1–TR16</b>) were synthesized and evaluated for their inhibitory activities against monoamine oxidase A and B (MAOs). Most of the derivatives showed potent and highly selective MAO-B inhibition. …”
    Get full text
    Article
  15. 115

    Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors by Vedanjali Gogineni, Manal A. Nael, Narayan D. Chaurasiya, Khaled M. Elokely, Christopher R. McCurdy, John M. Rimoldi, Stephen J. Cutler, Babu L. Tekwani, Francisco León

    Published 2021-09-01
    “…A series of dietary flavonoid acacetin 7-<i>O</i>-methyl ether derivatives were computationally designed aiming to improve the selectivity and potency profiles against monoamine oxidase (MAO) B. The designed compounds were evaluated for their potential to inhibit human MAO-A and -B. …”
    Get full text
    Article
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120